Earnings Summary

Silk Road Medical Inc’s revenue jumped 17.97% since last year same period to $47.27Mn in the Q4 2023. On a quarterly growth basis, Silk Road Medical Inc has generated 6.38% jump in its revenue since last 3-months.

Silk Road Medical Inc’s net profit fell -3.28% since last year same period to $-13.01Mn in the Q4 2023. On a quarterly growth basis, Silk Road Medical Inc has generated -1.74% fall in its net profits since last 3-months.

Silk Road Medical Inc’s net profit margin jumped 12.45% since last year same period to -27.52% in the Q4 2023. On a quarterly growth basis, Silk Road Medical Inc has generated 4.36% jump in its net profit margins since last 3-months.

Silk Road Medical Inc’s earning per share (EPS) estimates for the current quarter stand at -0.4 - a 4.76% jump from last quarter’s estimates.

Silk Road Medical Inc’s earning per share (EPS) estimates for the current year stand at -0.4.

Silk Road Medical Inc’s earning per share (EPS) jumped 2.94% since last year same period to -0.33 in the Q4 2023. This indicates that the Silk Road Medical Inc has generated 2.94% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Silk Road Medical Inc’s return on assets (ROA) stands at -0.14.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Silk Road Medical Inc’s return on equity (ROE) stands at -0.35.